Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022

SELL
$22.67 - $28.01 $18,136 - $22,408
-800 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$24.13 - $32.63 $19,304 - $26,104
800 New
800 $22,000
Q1 2021

May 17, 2021

SELL
$19.92 - $31.6 $272,904 - $432,920
-13,700 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$12.16 - $19.77 $136,192 - $221,424
11,200 Added 448.0%
13,700 $271,000
Q3 2020

Nov 16, 2020

SELL
$11.25 - $14.75 $133,875 - $175,525
-11,900 Reduced 82.64%
2,500 $33,000
Q2 2020

Aug 14, 2020

SELL
$10.69 - $16.49 $519,534 - $801,413
-48,600 Reduced 77.14%
14,400 $163,000
Q1 2020

May 15, 2020

BUY
$9.78 - $29.53 $110,514 - $333,689
11,300 Added 21.86%
63,000 $902,000
Q4 2019

Feb 14, 2020

BUY
$20.93 - $35.1 $876,967 - $1.47 Million
41,900 Added 427.55%
51,700 $1.41 Million
Q3 2019

Nov 14, 2019

BUY
$22.08 - $47.08 $83,904 - $178,904
3,800 Added 63.33%
9,800 $281,000
Q2 2019

Aug 14, 2019

SELL
$22.67 - $35.0 $124,685 - $192,500
-5,500 Reduced 47.83%
6,000 $167,000
Q1 2019

May 15, 2019

SELL
$26.93 - $34.7 $673,250 - $867,500
-25,000 Reduced 68.49%
11,500 $382,000
Q4 2018

Feb 14, 2019

BUY
$27.23 - $45.56 $544,600 - $911,200
20,000 Added 121.21%
36,500 $1.06 Million
Q3 2018

Nov 14, 2018

SELL
$37.57 - $50.34 $26,299 - $35,238
-700 Reduced 4.07%
16,500 $759,000
Q2 2018

Aug 14, 2018

BUY
$27.75 - $40.17 $468,975 - $678,873
16,900 Added 5633.33%
17,200 $643,000
Q1 2018

May 15, 2018

SELL
$28.83 - $41.01 $17,298 - $24,606
-600 Reduced 66.67%
300 $9,000
Q4 2017

Feb 14, 2018

SELL
$28.45 - $37.14 $184,925 - $241,410
-6,500 Reduced 87.84%
900 $30,000
Q3 2017

Nov 14, 2017

SELL
$24.01 - $36.2 $722,701 - $1.09 Million
-30,100 Reduced 80.27%
7,400 $268,000
Q2 2017

Aug 14, 2017

BUY
N/A
37,500
37,500 $969,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.24B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.